Care That Starts With the Individual
People with similar symptoms may have different medical histories, goals, daily routines, and responses to treatment. Those differences matter when deciding how to assess pain and what care to consider. An individualized plan starts with the person, not just a diagnosis.
Genetic information can sometimes help inform decisions, such as medication choice, but it is only one possible part of the picture. Symptoms, prior treatments, overall health, lifestyle, and personal preferences also guide clinical assessment. Genetic findings do not predict every health outcome, and they do not establish which regenerative treatment will work for a particular person.
Advanced Integrative Medicine takes a conservative, patient-centered approach to pain care, including non-surgical options such as platelet-rich plasma therapy. Treatment decisions still depend on an individual evaluation and discussion of goals, benefits, and limitations. The aim is to choose a reasonable plan and assess how it is working, not to promise a particular result.
Personalized Medicine in Pain Care
Personalized medicine uses information about a person to guide prevention, diagnosis, treatment, and follow-up, rather than assuming one approach will work for everyone. The National Human Genome Research Institute’s definition of personalized medicine highlights genetic information, but pain care also draws on a broader clinical picture.
That picture can include where pain occurs, how it changes over time, medical history, daily activities, and what the patient hopes to do more comfortably. At Advanced Integrative Medicine, a conservative, patient-centered approach considers these factors when discussing non-surgical options, including platelet-rich plasma therapy, for conditions such as back pain and sports injuries.
Patients and clinicians can weigh possible benefits, limits, and risks together, then track whether care supports meaningful goals such as improved movement or daily function. Federation of State Medical Boards pain-management guidance emphasizes individualized decisions and shared discussion, including when considering medication or non-drug approaches.
Depending on the assessment, a plan may involve movement or physical therapy, medication, behavioral strategies, or a procedure. Advanced Integrative Medicine focuses on alternatives to surgery and supporting the body’s recovery, but regenerative treatments are not suitable or effective for every person. Monitoring symptoms, function, and side effects helps patients and clinicians decide whether to continue, change, or reconsider an approach.
Assessing Pain and Treatment Goals
How is pain assessed to guide an evidence-based treatment plan? It starts with the patient’s description. A rating from zero to ten can help screen pain, but it cannot capture the whole experience or guide care by itself.
A clinician may ask when the pain began, where it is and whether it spreads, how it feels, when it occurs, and what worsens or eases it. Prior treatments and their effects matter, as does the patient’s understanding of the cause. Medical history, examination findings, and the effect of pain on work, sleep, mobility, and other daily activities add context.
Goals should be specific to the person, such as returning to a valued activity or completing everyday tasks with less difficulty. This patient-centered approach aligns with pain-management guidance emphasizing shared decisions and individual circumstances. At Advanced Integrative Medicine, the conservative, non-surgical approach considers a patient’s needs when discussing options such as platelet-rich plasma therapy.
At follow-up, using consistent measures and revisiting the same functional goals helps show whether care is making a meaningful difference. The plan can then be adjusted in proportion to the response, while weighing likely benefits, risks, and the patient’s preferences.
Treatment Options for Persistent Pain
What evidence-based treatments can help manage chronic pain? Care is usually matched to the condition, a person’s goals, and how symptoms affect daily life. Rather than relying on one intervention, a plan may combine movement, education, behavioral support, and medical treatment. The Federation of State Medical Boards’ pain-management guidance emphasizes individualized decisions and thoughtful consideration of nonpharmacological options alongside medication when appropriate (AMA overview of the guidance).
Exercise and physical therapy can help build or maintain function, while education can help people understand pain and take part in care decisions. Cognitive behavioral therapy and mindfulness-based approaches may support coping. Depending on the pain condition, a clinician may also consider topical medicines for localized neuropathic pain, anti-inflammatory drugs, or certain antidepressants or anticonvulsants. Benefits, side effects, and changing needs should be reviewed over time.
For selected patients who have not improved with conservative care, targeted procedures or neuromodulation may be considered after a clinical evaluation. Advanced Integrative Medicine focuses on non-surgical pain care, including platelet-rich plasma (PRP) therapy for some musculoskeletal conditions. Evidence for PRP and other regenerative treatments varies by condition, and genetic profiling has not been shown to identify who will benefit. Discuss potential benefits, uncertainties, and alternatives with a qualified clinician before choosing a treatment.
Movement for Low Back Pain
What evidence-based exercises can help relieve low back pain? For many people with nonspecific low back pain, guidance favors staying active and using therapeutic exercise rather than prolonged bed rest. [The American College of Physicians’ guideline](https://pmc.ncbi.nlm.nih.gov/articles/PMC11981433/) is not available in the provided sources, so the available evidence here supports a broader point: movement should be matched to a person’s symptoms and abilities.
Walking, gentle mobility, and exercises that strengthen the trunk and hips can be practical starting points. A physical therapist can help adapt the pace, range of motion, and exercise choice to the person’s condition. At Advanced Integrative Medicine, care is described as conservative and patient-centered, with attention to non-surgical options for pain.
For persistent pain, structured programs may include motor-control or core-stabilization work, progressive strengthening, and mind-body movement such as yoga or tai chi. There is no single best routine for everyone. Begin gradually, and modify an activity if it causes a substantial or lasting increase in pain; progress can depend on comfort, function, and recovery between sessions.
Pause exercise and seek medical advice before continuing if you have new weakness, numbness around the groin or saddle area, or difficulty controlling your bladder or bowels. These symptoms need prompt clinical assessment rather than a self-directed exercise plan.
What Genetic Information Can Tell Us
Genetic differences can be associated with disease risk or progression, and some can affect how a person responds to a medication. They do not, by themselves, determine a person’s health or identify the right treatment for every kind of pain.
Pharmacogenomics studies how genetic variation may influence a medicine’s metabolism, effectiveness, or risk of side effects. It can inform medication choices when the evidence is relevant to a particular drug, but this medication-focused use should not be confused with evidence that genetic testing predicts response to platelet-rich plasma or other regenerative care. The National Human Genome Research Institute’s overview of personalized medicine describes genetic information as one input to clinical decisions, not a guarantee of an outcome.
One example involves CYP2D6, a gene that affects the processing of some opioids. Differences in CYP2D6 activity can mean that codeine or tramadol provides too little pain relief for some people, while unusually rapid processing can increase the risk of excessive drug effects. Clinicians may consider this information when weighing medication options, including nonopioid alternatives, but its relevance depends on the medicine and the patient’s circumstances. Pharmacogenomics guidance on pain medicines explains both the potential uses and limits of these findings.
Genes are only part of medication response. A person’s health conditions, age, other medicines, and additional non-genetic factors can affect how a drug works or whether a recommendation applies. Test results also need professional interpretation, since evidence and guidance differ among drugs.
At Advanced Integrative Medicine, pain care takes a conservative, patient-centered approach and considers a person’s condition and goals when discussing nonsurgical options. Genetic results, when relevant, should add context to that assessment rather than dictate treatment. Shared decisions and follow-up help clinicians and patients review whether a plan is working and adjust it as needed.
Benefits and Limits of Tailored Care
Personalized care may help clinicians choose a treatment that better fits a person’s health history, risks, and goals. When genetic information is relevant to a medication, it can sometimes inform drug choice or dosage, potentially reducing ineffective trials or avoidable side effects. The National Human Genome Research Institute’s overview of personalized medicine describes genetic information as one input to prevention and treatment decisions, not a guarantee of results.
For pain care, Advanced Integrative Medicine takes a conservative, patient-centered approach, considering non-surgical options such as platelet-rich plasma therapy within an individual’s clinical picture. That is different from medication-related pharmacogenomics, where genetic variation can inform decisions about certain drugs. The available sources do not establish that genetic profiling selects patients for, or predicts outcomes from, platelet-rich plasma or other regenerative pain treatments.
Tailoring care still depends on a thorough evaluation. Test results need interpretation alongside symptoms, medical history, other medications, and patient preferences; a genetic result alone cannot determine the best plan. The 2025 review of genomic medicine also identifies limits including testing costs, uneven access, privacy concerns, and the need for clinical expertise.
Tests and evidence do not answer every clinical question, and access to testing and specialist guidance is not equal for all patients. Genetic and health information also requires secure handling and clear communication about its use. For a person considering pain treatment, these limits support discussing what is known, what remains uncertain, and which options fit their circumstances before making a decision.
A Plan That Can Adapt
A useful pain-care plan brings together your priorities, medical history, examination, and evidence. A genetic result may add context when relevant, but it cannot explain every symptom or predict how treatment will work.
Ask a clinician whether a test or treatment applies to your situation, what its limits are, and how progress will be assessed. At Advanced Integrative Medicine, care emphasizes conservative, patient-centered options, including regenerative treatments, rather than assuming surgery is the next step.
As symptoms, function, or treatment response change, the plan can change too.
